EMMES BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

12/05/2011

VAT status

Active

Bankruptcy proceedings

No proceedings

EMMES BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

Not calculated

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Prescore cannot be calculated because the company delayed submission of financial statements.

Incorporation date

15/04/2011

Share capital

5,000.00 PLN

Primary activity

Other research and experimental development on natural sciences and engineering (72.19.Z - PKD 2007)

Representatives

Representatives rights

DO REPREZENTOWANIA SPÓŁKI, W TYM DO SKŁADANIA ORAZ PODPISYWANIA OŚWIADCZEŃ WOLI W IMIENIU SPÓŁKI, UPRAWNIONY JEST KAŻDY CZŁONEK ZARZĄDU DZIAŁAJĄCY SAMODZIELNIE

Representatives

No representatives

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
-	-

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

1,273,880

Net Profit (zł)

1,273,880

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2021
2,384,254
951,335
892,234
0.26
3.93
37.42
549,184
208,769
0
45,996

2022
3,974,594
1,167,410
1,057,217
0.33
4.06
26.60
1,606,401
427,846
0
-

2023
4,792,533
1,330,176
1,273,880
0.54
8.50
26.58
2,880,282
343,718
0
411,822

2023
4,792,533
1,330,176
1,273,880
0.54
8.50
26.58
2,880,282
343,718
0
411,822

Turnover (zł)

2023

Turnover (zł)

4,792,533 zł21 % *

Profit before tax (zł)

1,330,176 zł14 % *

Net Profit (zł)

1,273,880 zł20 % *

Working capital requirement (%)

0.54 63.64 % *

Liquidity ratio

8.50 109.36 % *

Net profitability (%)

26.58 %-0.08 % *

Equity (zł)

2,880,282 zł79 % *

Current liabilities (zł)

343,718 zł-20 % *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

411,822 zł- *

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

EMMES BIOPHARMA POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
06/11/2025	OD 01.01.2024 DO 31.12.2024
31/03/2024	OD 01.01.2023 DO 31.12.2023
30/05/2023	OD 01.01.2022 DO 31.12.2022
30/09/2022	OD 01.01.2021 DO 31.12.2021
16/07/2021	OD 01.01.2020 DO 31.12.2020